{
    "Case ID": "063648",
    "Crime_Name": [
        "Patent Dispute"
    ],
    "Crime_Type": [
        "Violations of Immigration Regulations"
    ],
    "Violation_Type": [],
    "Legal_Issue": [
        "Validity of the 924 Patent in terms of utility, sound prediction, and overbreadth"
    ],
    "Governing_Law": [
        "Canadian Patent Law"
    ],
    "Application_Facts": [
        "The court analyzed experiments in the 924 Patent and found insufficient evidence to demonstrate or predict utility across all claimed molecular weights of PVP; claims were broader than the actual invention shown"
    ],
    "Decision_Outcome": [
        "The 924 Patent is invalid due to lack of demonstrated or soundly predicted utility and overbreadth"
    ],
    "Remedy_Requested": [
        "Alcon sought to prevent Cobalt from selling a generic olopatadine product"
    ],
    "Court_Ruling": [
        "The court dismissed Alcon's application, declaring the 924 Patent invalid for lack of utility and overbreadth"
    ],
    "Claimant_Status": [
        "Alcon, patent holder seeking to block generic entry"
    ],
    "Defendant_Behavior": [
        "Cobalt filed a Notice of Objection challenging the validity of the 924 Patent"
    ],
    "Grounds_for_Claim": [
        "Lack of utility, overbreadth, insufficiency, ambiguity, and obviousness"
    ],
    "Legal_Standard": [
        "A patent must demonstrate or soundly predict its utility; claims must not be broader than the invention disclosed"
    ],
    "Assessment_Factor": [
        "Evidence of utility across claimed molecular weights, scope of claims relative to disclosure"
    ],
    "Applicable_Legislation": [
        "Canadian Patent Act"
    ],
    "Procedural_Issue": [
        "Notice of Objection (NOA) filed under regulatory process for drug patents"
    ],
    "Review_Standard": [],
    "Credibility_Assessment": [],
    "Evidence_Used": [
        "Experimental data within the 924 Patent"
    ],
    "Legal_Provision_Cited": [
        "Provisions related to utility, sound prediction, overbreadth, sufficiency, and clarity under Canadian patent law"
    ],
    "Application_Basis": [
        "Federal Court assessed patent claims based on legal challenges to validity"
    ],
    "Evidence_Assessed": [
        "Experimental results in the 924 Patent"
    ],
    "Relief_Sought": [
        "Injunction to prevent Cobalt from selling generic olopatadine"
    ],
    "Governing_Rule": [
        "Utility must be demonstrated or soundly predicted; claims must be supported by the specification"
    ],
    "Evidentiary_Deficiency": [
        "Insufficient evidence to demonstrate or predict utility for all claimed PVP molecular weights"
    ],
    "Outcome": [
        "Patent declared invalid, Alcon's application dismissed"
    ],
    "Decisional_Body": [
        "Federal Court of Canada"
    ],
    "Harm_Assessment": [],
    "Cause_Description": [
        "Alcon sought to prevent Cobalt from selling a generic olopatadine product by claiming the 924 Patent was valid"
    ],
    "Evidence_Handling": [
        "Court evaluated the adequacy and relevance of experimental data in the patent"
    ],
    "Legal_Provision_Violated": [
        "Requirements for utility and claim support under Canadian Patent Law"
    ],
    "Evidence_Issues": [
        "Data did not support utility across full scope of claims"
    ],
    "Residency_Compliance": [],
    "Misrepresentation_Element": [],
    "Legal_Provision": [
        "Canadian Patent Act provisions on utility, sound prediction, overbreadth"
    ],
    "Jurisdictional_Issue": [],
    "Evidence_Assessment": [
        "Findings that experiments failed to support broad claims"
    ],
    "Decision_Rationale": [
        "Claims were not supported by sufficient demonstration or prediction of utility and were overly broad"
    ],
    "Country_of_Origin": [],
    "Decision_Making_Body": [
        "Federal Court"
    ],
    "Evidentiary_Issues": [
        "Lack of data supporting utility across the full range of claimed molecular weights"
    ]
}